Spiral Perfusion Imaging with Consecutive Echoes (SPICE™) for the Simultaneous Mapping of DSC- and DCE-MRI Parameters in Brain Tumor Patients: Theory and Initial Feasibility
Author(s) -
E.S. Paulson,
D.E. Prah,
Kathleen M. Schmainda
Publication year - 2016
Publication title -
tomography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.074
H-Index - 9
eISSN - 2379-139X
pISSN - 2379-1381
DOI - 10.18383/j.tom.2016.00217
Subject(s) - magnetic resonance imaging , gadolinium , perfusion , contrast (vision) , perfusion scanning , dynamic contrast enhanced mri , dynamic contrast , spiral (railway) , biomedical engineering , nuclear medicine , materials science , radiology , medicine , computer science , artificial intelligence , mathematics , metallurgy , mathematical analysis
Dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI) are the perfusion imaging techniques most frequently used to probe the angiogenic character of brain neoplasms. With these methods, T 1 - and T 2 / T 2 *-weighted imaging sequences are used to image the distribution of gadolinium (Gd)-based contrast agents. However, it is well known that Gd exhibits combined T 1 , T 2 , and T 2 * shortening effects in tissue, and therefore, the results of both DCE- and DSC-MRI can be confounded by these opposing effects. In particular, residual susceptibility effects compete with T 1 shortening, which can confound DCE-MRI parameters, whereas dipolar T 1 and T 2 leakage and residual susceptibility effects can confound DSC-MRI parameters. We introduce here a novel perfusion imaging acquisition and postprocessing method termed Spiral Perfusion Imaging with Consecutive Echoes (SPICE) that can be used to simultaneously acquire DCE- and DSC-MRI data, which requires only a single dose of the Gd contrast agent, does not require the collection of a precontrast T 1 map for DCE-MRI processing, and eliminates the confounding contrast agent effects due to contrast extravasation. A detailed mathematical description of SPICE is provided here along with a demonstration of its utility in patients with high-grade glioma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom